North America Expansion Hytest is actively growing its customer-focused commercial organization in North America with new hires, signaling a strategic push to capture more market share in the region for diagnostic antibodies and antigens.

Quality Leadership Recent senior appointments in quality and compliance highlight a continued emphasis on regulatory excellence and reliability, which can be leveraged to win deals requiring stringent QA processes and validated supply.

New Antigen Launch The introduction of HIV-1 antigen Cat. # 8H11 expands Hytest’s reagent repertoire, presenting cross-selling opportunities to existing customers and a path to enter new assay development programs.

Broad Reagent Portfolio With experience across cardiac markers, infectious disease, neuroscience, and autoimmune reagents, Hytest can address diverse IVD development needs, enabling bundled or multi-target procurement conversations.

Reliability and Scale Revenue range and a 30+ year track record, combined with leadership changes in quality, position Hytest as a stable supplier for high-volume IVD manufacturers seeking dependable antibody and antigen supply chains.